{"id":2103,"date":"2026-08-29T17:30:00","date_gmt":"2026-08-29T17:30:00","guid":{"rendered":"https:\/\/netguide.io\/news\/?p=2103"},"modified":"2026-08-28T23:25:32","modified_gmt":"2026-08-28T23:25:32","slug":"lichtaktive-wirkstoffe-augentropfen-blinde-maeuse-sehen","status":"publish","type":"post","link":"https:\/\/netguide.io\/news\/de\/2026\/08\/29\/lichtaktive-wirkstoffe-augentropfen-blinde-maeuse-sehen\/","title":{"rendered":"Augentropfen gegen Blindheit: Lichtaktive Wirkstoffe lassen blinde M\u00e4use wieder sehen"},"content":{"rendered":"<div id=\"netgu-3958633169\" class=\"netgu-before-content netgu-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-6258556257245998\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-6258556257245998\" \ndata-ad-slot=\"3494115342\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p class=\"wp-block-paragraph\"><strong>Ein Forschungskonsortium hat lichtaktivierbare Wirkstoffe entwickelt, die blinde M\u00e4use wieder Licht wahrnehmen lie\u00dfen \u2013 ohne Gentherapie, Implantate oder spezielle Beleuchtung. Zwei der vielversprechendsten Verbindungen wirkten sogar als einfache Augentropfen.<\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Wirkstoffe statt Gentherapie<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Das vom Institut f\u00fcr Bioingenieurwesen Kataloniens (IBEC) gef\u00fchrte Konsortium nutzt die \u201ePhotopharmakologie&#8221; \u2013 eine Technik, mit der sich die Wirkung von Molek\u00fclen gezielt durch Licht steuern l\u00e4sst. Die neuen Verbindungen (genannt \u201eprosthe6&#8243;) \u00fcbernehmen die Funktion der Fotorezeptoren, die bei Erkrankungen wie der altersbedingten Makuladegeneration (AMD) und Retinitis pigmentosa absterben.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Ergebnisse in M\u00e4usen<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Vollst\u00e4ndig blinde M\u00e4use gewannen wenige Stunden nach der Behandlung \u2013 per Augentropfen oder Injektion ins Auge \u2013 ihre nat\u00fcrliche Vorliebe f\u00fcr dunkle Umgebungen zur\u00fcck, ein Zeichen wiederhergestellten Sehens. Die Tiere zeigten keine Anzeichen von Schmerz oder Sch\u00e4den am Auge.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Hoffnung, aber noch fr\u00fch<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Die Molek\u00fcle gelten als m\u00f6gliche Wirkstoffkandidaten f\u00fcr Menschen mit degenerativen Netzhauterkrankungen. Bis dahin ist es allerdings noch weit \u2013 bislang handelt es sich um fr\u00fche Forschung im Tiermodell.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Quellen: <a href=\"https:\/\/www.sciencedaily.com\/releases\/2026\/08\/260828005224.htm\" target=\"_blank\" rel=\"noopener\">ScienceDaily<\/a>, <a href=\"https:\/\/www.eurekalert.org\/news-releases\/1136093\" target=\"_blank\" rel=\"noopener\">EurekAlert<\/a>.<\/em><\/p>\n<div id=\"netgu-3962312221\" class=\"netgu-after-content netgu-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-6258556257245998\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-6258556257245998\" \ndata-ad-slot=\"4559785002\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Lichtaktivierbare Wirkstoffe lie\u00dfen blinde M\u00e4use wieder Licht wahrnehmen \u2013 ohne Gentherapie oder Implantate. Zwei Verbindungen wirkten als Augentropfen.<\/p>\n","protected":false},"author":1,"featured_media":2099,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[],"tags":[],"class_list":["post-2103","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry"],"brizy_media":[],"_links":{"self":[{"href":"https:\/\/netguide.io\/news\/wp-json\/wp\/v2\/posts\/2103","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/netguide.io\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/netguide.io\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/netguide.io\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/netguide.io\/news\/wp-json\/wp\/v2\/comments?post=2103"}],"version-history":[{"count":1,"href":"https:\/\/netguide.io\/news\/wp-json\/wp\/v2\/posts\/2103\/revisions"}],"predecessor-version":[{"id":2111,"href":"https:\/\/netguide.io\/news\/wp-json\/wp\/v2\/posts\/2103\/revisions\/2111"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/netguide.io\/news\/wp-json\/wp\/v2\/media\/2099"}],"wp:attachment":[{"href":"https:\/\/netguide.io\/news\/wp-json\/wp\/v2\/media?parent=2103"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/netguide.io\/news\/wp-json\/wp\/v2\/categories?post=2103"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/netguide.io\/news\/wp-json\/wp\/v2\/tags?post=2103"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}